Terns Pharmaceuticals, Inc. (TERN) NASDAQ

8.23

+0.2(+2.49%)

Updated at October 03 04:00PM

Currency In USD

Valuation

Market Cap440.47M
Enterprise Value280.38M
P/E Ratio-8.21
PEG Ratio-1.79
Price/Sales Ratio0
Price/Book Ratio2.47
Enterprise/Revenue0
Enterprise/EBITDA-5.65

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.29
Return On Equity-0.27

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-87.7M
Net Income-88.85M
Diluted EPS-1.12

Balance Sheet

Total Cash315.45M
Total Cash/Share3.44
Total Debt1.13M
Total Debt/Equity0
Current Ratio24.7
Book Value Per Share3.33

Price History

52-Week Change0.37
52-Week High8.46
52-Week Low1.87
Moving Average 50 Days6.89
Moving Average 200 Days4.68

Statistics

Average Volume1.09M
Shares Outstanding87.51M
% Held by Institutions90.75

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A